Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Oscar Health, Inc. filings on SEC EDGAR ↗
For the three months ended September 30, 2026, Oscar Health reported total revenue of $5.14 billion, a significant increase from $2.99 billion in the prior year period. The company achieved earnings from operations of $178.0 million and net earnings before taxes of $175.4 million, representing a substantial turnaround from the operating loss of $129.3 million reported in the third quarter of 2025.
Oscar Health reported Q3 2026 financial results with total revenue of $5.14 billion, a significant increase from $2.99 billion in the prior year. The company achieved net income of $167.3 million compared to a net loss in Q3 2025 and raised its full-year 2026 earnings from operations outlook to a range of $850 million to $950 million.
Term
Q3 2026
“Oscar Health is on track to deliver the strongest year of financial performance in our history, and we are raising our earnings from operations outlook for a third time. The ACA is the foundation of a rapidly-developing individual market in America, and Oscar Health is built to lead it. Our disciplined pricing, consumer-led products, and technology-powered approach are driving stronger economics and position us to grow market share and expand margin in 2027.”